Given the central role of Myc in many cancers, including RCC, inhibition of PIM-1 activity may promote Myc degradation and subsequently decrease tumour cell proliferation (Pelengaris et al, 2002; Nilsson and Cleveland, 2003; Tang et al, 2009). The gene discussed is MYC; the disease is neoplasm.